Copyright
©The Author(s) 2022.
World J Clin Oncol. Nov 24, 2022; 13(11): 929-942
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.929
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.929
Figure 2 Phylogenetic tree showing family and species of gut microbiome abundant in responders and non-responders to immune-checkpoint blockade therapy in all included studies.
Gut microbiome species highlighted in red: Abundant in non-responders to immune-checkpoint blockade therapy; blue: Abundant in responders to immune-checkpoint blockade therapy; purple: Abundant in both responders and non-responders.
- Citation: Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. World J Clin Oncol 2022; 13(11): 929-942
- URL: https://www.wjgnet.com/2218-4333/full/v13/i11/929.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i11.929